Skip to main content
CDRE
NYSE Industrial Applications And Services

Cadre Holdings Discloses $34.5M CEO Expense Reimbursement, Significant Potential Dilution, and Board Changes

Analysis by Wiseek.ai
Sentiment info
Negative
Importance info
9
Price
$29.15
Mkt Cap
$1.242B
52W Low
$28.22
52W High
$48.76
Market data snapshot near publication time

summarizeSummary

Cadre Holdings' definitive proxy statement reveals over $34.5 million in 'unallocated expense reimbursement' for its CEO, significant potential dilution from equity plans, and material related-party transactions with a CEO-owned entity, alongside changes to its Board of Directors.


check_boxKey Events

  • CEO Received Over $34.5 Million in Expense Reimbursement

    CEO Warren B. Kanders' 2025 compensation included $34,531,948 for 'unallocated expense reimbursement,' a highly unusual and substantial amount.

  • Significant Potential Dilution from Equity Plans

    As of December 31, 2025, 9,683,220 shares remained available for future issuance under equity compensation plans, representing a potential dilution of approximately 22.6% of current outstanding shares.

  • Material Related-Party Transactions Disclosed

    The company paid $3 million to Kanders & Company, a firm solely owned by CEO Warren B. Kanders, for support related to two acquisitions in 2025 and 2026.

  • Board of Directors Changes Proposed

    Two current directors, Deborah A. DeCotis and Gianmaria C. Delzanno, are not nominated for re-election, while Mary Kissel and former director Nicholas Sokolow are proposed as new board members.


auto_awesomeAnalysis

This definitive proxy statement reveals several significant corporate governance and compensation issues that could negatively impact investor sentiment, especially with the stock trading near its 52-week low. The most striking disclosure is the over $34.5 million in 'unallocated expense reimbursement' for CEO Warren B. Kanders in 2025, which is an exceptionally large compensation component. Additionally, the company's equity compensation plans have a substantial 22.6% potential dilution from shares available for future issuance, which could weigh on shareholder value. Material related-party transactions totaling $3 million were paid to Kanders & Company, a firm solely owned by the CEO, for acquisition support. The proposed changes to the Board of Directors, with two current members not standing for re-election and two new/returning nominees, also represent a notable shift in governance. Investors should scrutinize these compensation practices, potential dilution, and related-party dealings.

At the time of this filing, CDRE was trading at $29.15 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $1.2B. The 52-week trading range was $28.22 to $48.76. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed CDRE - Latest Insights

CDRE
Apr 24, 2026, 8:30 AM EDT
Filing Type: DEF 14A
Importance Score:
9
CDRE
Mar 30, 2026, 5:58 PM EDT
Filing Type: S-4
Importance Score:
7
CDRE
Mar 26, 2026, 10:24 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
CDRE
Mar 24, 2026, 4:15 PM EDT
Filing Type: 4
Importance Score:
7
CDRE
Mar 20, 2026, 6:03 PM EDT
Filing Type: 144
Importance Score:
8
CDRE
Mar 10, 2026, 4:26 PM EDT
Source: Reuters
Importance Score:
8
CDRE
Mar 10, 2026, 4:19 PM EDT
Filing Type: 10-K
Importance Score:
8
CDRE
Mar 10, 2026, 4:15 PM EDT
Filing Type: 8-K
Importance Score:
8
CDRE
Feb 02, 2026, 8:30 AM EST
Filing Type: 8-K/A
Importance Score:
8